Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Mitra Investindo Tbk. (MITI) vs Brigit Biofarmaka Teknologi Tbk. (OBAT)

Mitra Investindo Tbk.Trading
Brigit Biofarmaka Teknologi Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Mitra Investindo Tbk. dan Brigit Biofarmaka Teknologi Tbk.: Mitra Investindo Tbk. diperdagangkan di Rp188 (kapitalisasi pasar 723,85 M, volume 24 jam 801,6 rb), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp236 (kapitalisasi pasar 164,65 M, volume 24 jam 159,4 rb). Perbedaan utamanya: Mitra Investindo Tbk. jauh lebih besar — sekitar 4,4× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Mitra Investindo Tbk. lebih aktif diperdagangkan (801,6 rb vs 159,4 rb). Mana yang lebih baik tergantung tujuan investasimu.

MITIOBAT
Kapitalisasi Pasar
723,85 M164,65 M
Volume
801,6 rb159,4 rb
Lot
8,02 rb1,59 rb
Perputaran
151,72 jt37,68 jt
Harga Rata-rata
189,27236,38
Nilai Transaksi
151,72 jt37,68 jt
Harga Ekuilibrium Indikatif
195242
Volume Ekuilibrium Indikatif
13500

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

MITI
Lihat detail
OBAT
Lihat detail

Tentang Mitra Investindo Tbk.

PT Mitra Investindo Tbk (the Company) was established based on notarial deed No. 280 dated 16 September 1993 of Misahardi Wilamarta, S.H., notary in Jakarta, under the name of PT Minsuco International Finance. The Company's Articles of Association was amended several times, which one of the amendments was based on notarial deed No. 10 dated 15 March 2006 of Amrul Partomuan Pohan, S.H., llm., Notary in Jakarta, concerning the merger of PT Siwani Trinitra Tbk with PT Caraka Berkat Sarana to become PT Mitra Investindo Tbk.

Selengkapnya di halaman MITI

Tentang Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Selengkapnya di halaman OBAT